Navigation Links
Potassium Iodide Sales Surge on Heels of Large Government Order

MOORESVILLE, N.C., April 13, 2012 /PRNewswire/ -- A recent solicitation by the Defense Logistics Agency for 1,050,000 doses of Iosat Potassium Iodide has created a deluge of orders for emergency radiation products supplier Slated for troop support, the 130mg tablets provide protection against radioactive iodine in the event of a nuclear crisis. International concerns about the development of nuclear weaponry in Asia and the Middle East have also helped boost sales of the radiation drug to levels not seen in the past decade, except for last year's Fukushima nuclear reactor disaster in Japan. "We've been in business 13 years and have never seen such continued levels of stockpiling of potassium iodide," stated Troy Jones, President of "Last year during the Japan crisis we sold our normal 6-month supply of stock within 4 days with most of those orders going to U.S. west coast residents. Now we are trying to keep up with this sustained demand because of North Korea and Iran. Our wholesale orders to other websites, nuclear facilities and medical centers are starting to surpass our retail sales." Many wholesale orders of Iosat are the result of this week's viral news of the U.S. government's request for potassium iodide for its medical chain supply. also has a new 65mg Iosat Potassium Iodide tablet to add to its growing arsenal of radiation emergency products. The FDA-approved, half-strength tablet was developed as a safe and effective regimen for children. Though the current 130mg tab is scored and can be easily split for administration to children, the new Iosat-65 tab was created for ease of single unit dosing. Iosat-65 is currently restricted to overseas sales. is actively seeking international distributors for this newly FDA-approved radiation drug.

Stockpiling of potassium iodide is recommended by health officials worldwide to prevent thyroid cancer of those exposed to radioactive iodine in the event of a nuclear reactor accident or detonation of a nuclear bomb. FDA-approved in 1982, Potassium Iodide is available without a prescription. More information about FDA-approved potassium iodide can be found online at, celebrating its 13th year in business, is an Internet-based supplier and wholesaler of radiation emergency preparedness products that protect against dirty bomb radiation, nuclear reactor accidents and nuclear weapon fallout, and are used for radiation therapy/decontamination in hospitals. In early 2009, sold 5.4 million doses of FDA-approved ThyroShield™ Liquid Potassium Iodide to Kuwait's Ministry of Health and expects Government Emergency Preparedness grants and civilian orders to continue to drive sales of all its products well into 2012.



Contact: Troy Jones, President,
Ph: 866-283-3986 
631 Brawley School Rd. STE 407
Mooresville, NC 28117 

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at


Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Study Shows Nu-Tek's Modified Potassium Chloride Improves Yields in Meat Processing
2. 50,000 Potassium Iodide Pills Donated to Japan
3. Shortages of Potassium Iodide as Radiation Panic Drives Demand
4. Sales Contracts Worth $2.3 Million Signed Since 1 July 2008
5. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
6. AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
7. U.S. Hospital Sales Opportunities Maximized Through Functional Optimization
8. InVitria Expands Sales Team
9. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
10. Campbell Alliance Sales Practice to Present at CBIs Leadership Summit on Evolving the Pharma Sales Model
11. BioElectronics Corp Aggressively Expands Sales into Middle East
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider of ... , today announced that the company has set a new quarterly ... quarter on quarter growth posted for Q3 of 2014 to Q3 ... Mexico , with the establishment of an ... --> United Kingdom and ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
(Date:11/24/2015)... ... 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions for ... Aregger to serve as Chief Operating Officer. , Having joined InSphero in ... and was promoted to Head of InSphero Diagnostics in 2014. There she ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
(Date:10/29/2015)... Oct. 29, 2015 Daon, a global leader ... has released a new version of its IdentityX ... North America have already installed IdentityX ... includes a FIDO UAF certified server component ... to activate FIDO features. These customers include some of ...
Breaking Biology News(10 mins):